These 10 stocks could mint the next wave of millionaires › Ocugen (NASDAQ:OCGN), a biotechnology company developing gene therapies and regenerative medicine solutions for eye diseases, released its ...

Ocugen has scheduled a conference call and webcast for 8:30 a.m. ET today to discuss the financial results and recent business highlights. Ocugen’s executive leadership team will host the call, which ...

Eli Lilly’s Alzheimer’s disease (AD) drug donanemab has been recommended by the European Medicines Agency’s human medicines ...

Revenue (GAAP) surged to $31.7 million, exceeding analysts’ expectations by 88.8% driven by strong ZURZUVAE growth. Net loss (GAAP) narrowed to $49.7 million. This revenue surge, exceeding analysts’ ...

From new payload linkers to artificial intelligence partnerships, advances in ADC pipelines push forward selective cancer therapies that minimize side effects.

Fulgent Genetics (($FLGT)) has held its Q2 earnings call. Read on for the main highlights of the call. Fulgent Genetics recently held its earnings ...

Pelargonium cold and flu remedy Southern Africa harbours a botanical treasure that is finally receiving its scientific due. Meet Pelargonium sidoides – a South African plant proving its efficacy in ...

Peptide injections promising rapid recovery, muscle growth, and fat loss are gaining popularity among middle-aged men—but ...

Advances in instruments and tools, as well as focused collaborations, improve accuracy and extend the range of applications.

Get expert cardiology care in McKinney with advanced treatments, local access, and trusted physicians at Baylor Scott & White The Heart Hospital–McKinney.

Amicus Therapeutics is building momentum with strong sales growth from GALAFOLD and POMBILITI/OPFOLDA. Click here to find out ...

Discover how statistics influences your daily life, from weather forecasts to social media algorithms, making data-driven decisions routine.